Latanoprost Pensa Pharma (Latanoprost)

Latanoprost binds to FP receptors on the ciliary muscle, triggering a biochemical cascade that remodels extracellular matrix and enhances uveoscleral outflow of aqueous humor. The increased outflow lowers intra‑ocular pressure, reducing mechanical stress on the optic nerve and slowing glaucomatous damage.

The prescribed dose of Latanoprost Pensa Pharma is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact regimen, frequency, and duration are individualized based on the patient’s condition and response.

The safety of latanoprost in pregnancy and lactation has not been established, and it is classified as pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the prescribing clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and a strong intra‑ocular pressure‑lowering effect. Compared with beta‑blockers or carbonic anhydrase inhibitors, latanoprost often provides greater pressure reduction with a favorable dosing schedule, though individual response and side‑effect profiles may vary.

Latanoprost Pensa Pharma should be stored at ambient temperature, away from direct sunlight and moisture. Keep the bottle tightly closed, store in the original packaging, and avoid freezing. If the solution appears discolored or contains particles, discard it and obtain a new bottle.

The medication is administered as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place one drop into the conjunctival sac of the affected eye(s). Close the eye gently for a few seconds and avoid blinking excessively.

Serious risks, although rare, include severe eye inflammation such as uveitis, corneal edema, allergic reactions that may lead to contact dermatitis, and sudden loss of vision. Patients should seek immediate medical attention if they experience intense eye pain, vision changes, or signs of infection.

Latanoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and it should be avoided in eyes with active intra‑ocular inflammation, infection, or recent ocular surgery unless directed by a specialist. Caution is also advised for patients with a history of severe ocular surface disease.